Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy
NCT00312780
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
125
Enrollment
INDUSTRY
Sponsor class
Conditions
Albuminuria
Diabetic Nephropathy
Interventions
DRUG:
XL784
Sponsor
Symphony Evolution, Inc.